120 related articles for article (PubMed ID: 35913110)
1. Chitinase 3-Like 2.
Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Chickabasaviah YT; Somanna S; Arivazhagan A; Kondaiah P; Santosh V
Am J Clin Pathol; 2022 Oct; 158(4):521-529. PubMed ID: 35913110
[TBL] [Abstract][Full Text] [Related]
2. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.
Kruthika BS; Sugur H; Nandaki K; Arimappamagan A; Paturu K; Santosh V
J Clin Pathol; 2019 Oct; 72(10):677-681. PubMed ID: 31270134
[TBL] [Abstract][Full Text] [Related]
4. M2 Macrophage Marker Chitinase 3-Like 2 (CHI3L2) Associates With Progression of Conventional Renal Cell Carcinoma.
Pusztai C; Yusenko MV; Banyai D; Szanto A; Kovacs G
Anticancer Res; 2019 Dec; 39(12):6939-6943. PubMed ID: 31810965
[TBL] [Abstract][Full Text] [Related]
5. M2 macrophage marker CHI3L2 could serve as a potential prognostic and immunological biomarker in glioma by integrated single-cell and bulk RNA-Seq analysis.
Qian W; Wang Q; Zhang C; Zhu J; Zhang Q; Luo C
J Gene Med; 2023 Sep; 25(9):e3523. PubMed ID: 37147894
[TBL] [Abstract][Full Text] [Related]
6. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
8. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
Front Oncol; 2021; 11():611038. PubMed ID: 33937022
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
Møllgaard M; Degn M; Sellebjerg F; Frederiksen JL; Modvig S
Eur J Neurol; 2016 May; 23(5):898-905. PubMed ID: 26872061
[TBL] [Abstract][Full Text] [Related]
10. CSF chitinase proteins in amyotrophic lateral sclerosis.
Thompson AG; Gray E; Bampton A; Raciborska D; Talbot K; Turner MR
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1215-1220. PubMed ID: 31123140
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma.
Kruthika BS; Jain R; Arivazhagan A; Bharath RD; Yasha TC; Kondaiah P; Santosh V
J Neurooncol; 2019 Jan; 141(2):315-325. PubMed ID: 30460633
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
Lemée JM; Clavreul A; Menei P
Neuro Oncol; 2015 Oct; 17(10):1322-32. PubMed ID: 26203067
[TBL] [Abstract][Full Text] [Related]
13. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
14. Survival kinase genes present prognostic significance in glioblastoma.
Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
[TBL] [Abstract][Full Text] [Related]
15. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
16. Morphological differentiation of peritumoral brain zone microglia.
Salas-Gallardo GA; Lorea-Hernández JJ; Robles-Gómez ÁA; Del Campo CC; Peña-Ortega F
PLoS One; 2024; 19(3):e0297576. PubMed ID: 38451958
[TBL] [Abstract][Full Text] [Related]
17. Chitinase 3-like 2 protein monoclonal antibodies.
Avdieiev S; Savinska L; Filonenko V; Kavsan V
Hybridoma (Larchmt); 2012 Feb; 31(1):32-9. PubMed ID: 22316483
[TBL] [Abstract][Full Text] [Related]
18. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.
Lemée JM; Clavreul A; Aubry M; Com E; de Tayrac M; Eliat PA; Henry C; Rousseau A; Mosser J; Menei P
J Neurooncol; 2015 Mar; 122(1):53-61. PubMed ID: 25559687
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of primary and recurrent human glioblastoma multiforme using the small animal imaging and molecular expressive profiles.
Lin LT; Chiou SH; Lee TW; Liu RS; Hwang JJ; Chang CH; Ma HI; Lee YJ
Mol Imaging Biol; 2013 Jun; 15(3):262-72. PubMed ID: 22948536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
